Investor Presentation - First Six Months of 2021
40
Investor presentation First six months of 2021
The total branded diabetes market has a global value of DKK
~300 billion annually
DKK
Global diabetes market
DKK
The USA
0%
billion
billion
150
146 139
350
+4%
2019/2020 2020/2021 ☐ Growth at CER
-14%
294 292
100
+17%
300
57
47
52 59
-13%
+11%
50
250
21 18
16 17
0
200
Total
Insulin
GLP-1
DPP-IV
SGLT-2
-5%
150
130
DKK
billion
Outside the USA
+8%
118
148 153
+20%
150
100
-4%
80
70
60 55
+22%
100
+3%
73 72
+1%
50
33 38
50
+22%
18 22
+32%
39 38
17 22
0
Total
0
Insulin
GLP-1
DPP-IV
SGLT-2
Total
Insulin
GLP-1
DPP-IV
SGLT-2
Source: Company announcements.
Note: The segment value is based on reported figures, whilst the market growth is under constant exchange rate (CER). For Novo Nordisk the diabetes growth includes Insulin and GLP-1, excluding 'other diabetes care'.
Novo NordiskⓇView entire presentation